Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Astrocytoma 8Glioblastoma 5Prostatic Neoplasms 4Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Pituitary Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2trametinib 1tozuleristide 1tovorafenib 1tocilizumab 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vemurafenib 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Qsymia 1Phentermine 1Oxytocin 1Methionine 1Memantine 1Medication Errors 1Ginkgo biloba extract 1Exenatide 1Donepezil 1Contrast Media 1CKD732 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Craniopharyngioma × antineoplaston AS 2-1 × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡